Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 2,430 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Learning Disorders Clear all

Conditions: Fabry Disease
Interventions: Lucerastat; Drug
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 8
States / cities: Birmingham, Alabama • Oakland, California • Gainesville, Florida + 5 more

Conditions: Diabetes Type 2
Interventions: Dulce Digital Text-Based Education, Project Dulce Telehealth, Project Dulce Live; Behavioral
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Chula Vista, California • San Diego, California

Conditions: Major Depressive Disorder
Interventions: Genecept Assay; Device
Lead sponsor: Genomind, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Cerebrovascular Accident
Interventions: upper limb rehabilitation for chronic stroke; Other
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 21 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: CHF - Congestive Heart Failure
Interventions: Digital Outreach; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 13,714 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer, Pancreas Cancer, Colorectal Cancer, Endometrial Cancer, Prostate Cancer
Interventions: Relational Agent (RA), Enhanced Usual Care (EUC); Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Cancer Survivor, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: Educational Intervention; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Duarte, California

Conditions: COVID-19
Interventions: nirmatrelvir, ritonavir, placebo for nirmatrelvir; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 67
States / cities: Mesa, Arizona • Phoenix, Arizona • Surprise, Arizona + 47 more

Conditions: Overweight and Obesity
Interventions: SMART device; Device
Lead sponsor: Scientific Intake Limited Co.; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: San Diego, California • Waterbury, Connecticut • Coral Gables, Florida + 1 more

Conditions: Asthma
Interventions: tilrekimig, Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years to 80 Years
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 11
States / cities: River Forest, Illinois • Hannibal, Missouri • The Bronx, New York + 8 more

Conditions: HIV Infections, Hepatitis B
Interventions: Enhanced HIV risk reduction and HIV vaccine education; Behavioral
Lead sponsor: New York Blood Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Autism Spectrum Disorder
Interventions: STEPS, Services as usual (SAU); Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 16 Years to 25 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Stroke, Hypertension
Interventions: Educational intervention for diet and physical activity, Educational message on skin cancer awareness; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 760 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: First Episode Psychosis (FEP)
Interventions: EPI-CAL data network, Community DUP Assessment Tool; Combination Product · Diagnostic Test
Lead sponsor: University of California, Davis; Other
Eligibility: 8 Years to 40 Years
Enrollment: 736 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: End-stage Renal Disease
Interventions: Live Donor Champion Program; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 2
States / cities: St Louis, Missouri • Philadelphia, Pennsylvania

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Carcinoma, Metastatic Malignant Solid Neoplasm, Prognostic Stage IV Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
Interventions: Health Education, Questionnaire Administration; Behavioral · Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 4
States / cities: Columbus, Ohio • Lima, Ohio • Richmond, Ohio + 1 more

Conditions: Type 2 Diabetes Mellitus
Interventions: Carbohydrate-restricted diet, Mindfuless; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stroke, Chronic, Aging, Cognitive Decline, Motor Dysfunction, Neuroplasticity
Interventions: High intensity cycling, Low-intensity cycling, Health education session, Moderate Intensity Aerobic Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Asthma
Interventions: Reinforced Asthma Education; Behavioral
Lead sponsor: University of Louisville; Other
Eligibility: 5 Years to 12 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Parkinson's Disease (PD), Alzheimer's Disease (AD) and Related Disorders, Older Adults (60 - 85 Years Old)
Interventions: Complex Rhythmic Movement Sequences (CRMS) Sessions; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Sleep Apnea, Obstructive
Interventions: CPAP + Peer Support, CPAP + Individual Education; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Aortic Stenosis
Interventions: Transthoracic echocardiogram; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 65 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: New Haven, Connecticut • New York, New York • Houston, Texas

Conditions: Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), Intellectual Disability, Learning Disorder, Communication Disorders, Down Syndrome, Fragile X Syndrome, Motor Tic Disorders
Interventions: EMPOWER-ND; Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections
Interventions: Healthy Futures parent education; Behavioral
Lead sponsor: Education Development Center, Inc.; Industry
Eligibility: 11 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Newton, Massachusetts

Search by objective public record fields.

A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease

Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation

Digital Outreach for Heart Failure Adherence

Choices About Genetic Testing And Learning Your Risk With Smart Technology

Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Safety and Efficacy of the SMART Device for Overweight and Obese Adults

A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

STEPS Implementation Trial

Stroke Health and Risk Education (SHARE)

California Collaborative Network to Promote Data Driven Care and Improve Outcomes in Early Psychosis

Implementation of the Live Donor Champion Program

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

(R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger

AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions

Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma

Moving Yourself in Space and Time: MYSTIC

Group-based Peer Support Versus Individual Education for Patients Undergoing CPAP Treatment

Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study

Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance

Reducing HIV Risks in African American Teens